Literature DB >> 8778606

Renal-cell carcinoma.

R J Motzer1, N H Bander, D M Nanus.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8778606     DOI: 10.1056/NEJM199609193351207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  449 in total

1.  New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.

Authors:  A J van den Eertwegh ; H M Pinedo
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

Review 2.  Immunotherapy for renal carcinoma: theoretical basis and current standard of care.

Authors:  P A Vasey
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

Review 3.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

4.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

Review 5.  Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature.

Authors:  Paul H Chung; Ramaprasad Srinivasan; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  Urol Oncol       Date:  2011-02-01       Impact factor: 3.498

Review 6.  [Complementary and alternative medicine in urologic oncology].

Authors:  T Otto; J Suhr; H Rübben
Journal:  Urologe A       Date:  2003-11       Impact factor: 0.639

7.  New antiangiogenic agents for renal cell carcinoma: interferon alfa and thalidomide.

Authors:  Ronald M Bukowski
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

8.  Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.

Authors:  H Aksoy; S Baltaci; K Türkölmez; I Seçkiner; Y Bedük
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

9.  Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.

Authors:  Won K Han; Anwar Alinani; Chin-Lee Wu; Dror Michaelson; Massimo Loda; Francis J McGovern; Ravi Thadhani; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2005-03-02       Impact factor: 10.121

10.  Molecular targeted therapies of renal cell carcinoma considering life stage of the patient: Two case reports.

Authors:  Hisashi Takeuchi; Naoto Tokuyama; Isao Kuroda; Teiichiro Aoyagi
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.